- COVID-19 vaccines from AstraZeneca Plc AZN and Pfizer Inc PFE saved an estimated 12 million lives, Bloomberg reported citing a new analysis from Airfinity Ltd.
- The AstraZeneca vaccine developed by the University of Oxford saved 6.3 million lives, Airfinity said. The estimate for the Pfizer-BioNTech SE BNTX shot was 5.9 million.
- According to the report, the companies swiftly scaled up production and delivered doses before other manufacturers.
- The findings build on a study last month estimating that vaccines saved about 20 million lives in the first year, mostly in wealthier countries.
- More than 7 million deaths were likely averted in countries covered by Covax, the World Health Organization-backed distribution program highlighting the uneven access.
- The data shows that about one in five lives lost due to Covid in poorer countries could have been prevented if WHO targets had been reached.
- Airfinity determined that the vaccines of Sinovac Biotech Ltd SVA and Moderna Inc MRNA saved about 2 million and 1.7 million lives, respectively.
- Photo by Johaehn from Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: BiotechLarge CapNewsHealth CareTop StoriesGeneralBriefsCOVID-19 CoronavirusCOVID-19 Vaccine
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in